Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
-

Drugs

  • Share Share this page
-

Pergolide (marketed as Permax) Information

FDA today announces that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients’ heart valves.

    
-

Related Information

-
 

Contact Us

  • Report a Serious Problem

  • 1-800-332-1088
  • 1-800-FDA-0178 Fax

    • MedWatch Online

    Regular Mail: Use postage-paid FDA Form 3500

    Mail to: MedWatch 5600 Fishers Lane

    Rockville, MD 20852-9787

-
-
-
-
-
-